iRhythm Holdings, Inc. (IRTC)
Data as of , from SEC Form 4 filings.
See up to 3 months of IRTC. The 7-day demo opens the 1M and 3M ranges and puts IRTC on your watchlist.
Start 7-day demoLatest IRTC insider trades
About iRhythm Holdings, Inc. (IRTC)
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
- San Francisco, CA
- 2,400
- 2016
- XNAS
IRTC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 9 | 59,724 | $7.43M |
| Grant or award | 5 | 99,007 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
IRTC insider transactions (Form 4)
4783 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daniel G. Wilson - Officer | Open-market sale | Common Stock | 773 footnote F1 | $121.83 | $94K | |
| ||||||
| Quentin S. Blackford - Officer | Grant or award | Common Stock | 48,534 footnote F1 | $0.00 | - | |
| Quentin S. Blackford - Officer | Open-market sale | Common Stock | 26,859 footnote F2 | $124.65 | $3.35M | |
| ||||||
| Patrick Michael Murphy - Officer | Grant or award | Common Stock | 13,589 footnote F1 | $0.00 | - | |
| Patrick Michael Murphy - Officer | Open-market sale | Common Stock | 7,093 footnote F2 | $124.65 | $884K | |
| ||||||
| Grant or award | Common Stock | 13,589 footnote F1 | $0.00 | - | ||
| Open-market sale | Common Stock | 7,093 footnote F2 | $124.65 | $884K | ||
| ||||||
| Sumi Shrishrimal - Officer | Grant or award | Common Stock | 9,706 footnote F1 | $0.00 | - | |
| Sumi Shrishrimal - Officer | Open-market sale | Common Stock | 5,372 footnote F2 | $124.65 | $670K | |
| ||||||
| Minang Turakhia - Officer | Grant or award | Common Stock | 13,589 footnote F1 | $0.00 | - | |
| Minang Turakhia - Officer | Open-market sale | Common Stock | 7,093 footnote F2 | $124.65 | $884K | |
| ||||||
| Mervin Smith - Officer | Open-market sale | Common Stock | 617 footnote F1 | $122.12 | $75K | |
| ||||||
| Julianne Rodda - Officer | Open-market sale | Common Stock | 2,112 footnote F1 | $122.12 | $258K | |
| ||||||
| Open-market sale | Common Stock | 2,712 footnote F1 | $122.12 | $331K | ||
| ||||||
| Minang Turakhia - Officer | Open-market sale | Common Stock | 1,423 footnote F1 | $124.71 | $177K | |
| ||||||
| Sean Clinton Freeman - Officer | Open-market sale | Common Stock | 918 footnote F1 | $124.71 | $114K | |
| ||||||
| Sumi Shrishrimal - Officer | Grant or award | Common Stock | 133 footnote F1 | $96.82 | $13K | |
| Sumi Shrishrimal - Officer | Open-market sale | Common Stock | 1,716 footnote F2 | $108.19 | $186K | |
| ||||||
| Grant or award | Common Stock | 178 footnote F1 | $96.82 | $17K | ||
| Open-market sale | Common Stock | 729 footnote F2 | $108.19 | $79K | ||
| ||||||
| Minang Turakhia - Officer | Grant or award | Common Stock | 137 footnote F1 | $96.82 | $13K | |
| ||||||
| Grant or award | Common Stock | 177 footnote F1 | $96.82 | $17K | ||
| ||||||
| Sean Clinton Freeman - Officer | Grant or award | Common Stock | 273 footnote F1 | $96.82 | $26K | |
| ||||||
| Quentin S. Blackford - Officer | Grant or award | Common Stock | 178 footnote F1 | $96.82 | $17K | |
| ||||||
| Merz Cathleen Noel Bairey - Director | Grant or award | Common Stock | 1,573 footnote F1 | $0.00 | - | |
| ||||||
| Bruce G. Bodaken - Director | Grant or award | Common Stock | 1,573 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Common Stock | 1,573 footnote F1 | $0.00 | - | ||
| ||||||
| Grant or award | Common Stock | 1,573 footnote F1 | $0.00 | - | ||
| ||||||
| Grant or award | Common Stock | 1,573 footnote F1 | $0.00 | - | ||
| ||||||
| Grant or award | Common Stock | 1,573 footnote F1 | $0.00 | - | ||
| ||||||
| Brian B. Yoor - Director | Grant or award | Common Stock | 1,573 footnote F1 | $0.00 | - | |
| ||||||
| Open-market purchase | Common Stock | 5,312 footnote F1 | $10.71 | $57K | ||
| Open-market sale | Common Stock | 940 footnote F1 | $116.05 footnote F2 | $109K | ||
| Open-market sale | Common Stock | 642 footnote F1 | $116.98 footnote F3 | $75K | ||
| Open-market sale | Common Stock | 2,293 footnote F1 | $118.02 footnote F4 | $271K | ||
| Open-market sale | Common Stock | 1,147 footnote F1 | $119.16 footnote F5 | $137K | ||
| Open-market sale | Common Stock | 290 footnote F1 | $120.53 | $35K | ||
| Option exercise | Employee Stock Option (right to buy) | 5,312 | $10.71 | $57K | ||
| ||||||
| Brian Lee Lawrence - Officer | Open-market sale | Common Stock | 1,014 footnote F1 | $120.80 | $122K | |
| ||||||
| Jason H. Patten - Director | Grant or award | Common Stock | 2,218 footnote F1 | $0.00 | - | |
| ||||||
| Mervin Smith - Officer | Open-market sale | Common Stock | 2,585 footnote F1 | $114.30 | $295K | |
| ||||||
| Minang Turakhia - Officer | Open-market sale | Common Stock | 1,487 footnote F1 | $128.45 | $191K | |
| Minang Turakhia - Officer | Open-market sale | Common Stock | 1,310 footnote F1 | $128.45 | $168K | |
| Minang Turakhia - Officer | Open-market sale | Common Stock | 1,230 footnote F1 | $128.45 | $158K | |
| ||||||
| Sumi Shrishrimal - Officer | Open-market sale | Common Stock | 978 footnote F1 | $128.44 | $126K | |
| Sumi Shrishrimal - Officer | Open-market sale | Common Stock | 946 footnote F1 | $128.44 | $122K | |
| Sumi Shrishrimal - Officer | Open-market sale | Common Stock | 906 footnote F1 | $128.44 | $116K | |
| ||||||
Recent IRTC Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
IRTC insider trading FAQ
What is the latest insider trade for IRTC?
iRhythm Holdings, Inc. (IRTC) had 9 insider filings in the last 90 days, with the most recent on 2026-09-03. The full record for IRTC runs to 83 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IRTC stock?
No insider purchases of IRTC were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling IRTC stock?
9 insider sales of IRTC were filed in the last 90 days, totaling $7.43M.
Where can I see IRTC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IRTC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Daniel G. Wilson view on EDGAR
- - Quentin S. Blackford view on EDGAR
- - Patrick Michael Murphy view on EDGAR
- - Chad Patterson view on EDGAR
- - Sumi Shrishrimal view on EDGAR
- - Minang Turakhia view on EDGAR
- - Mervin Smith view on EDGAR
- - Julianne Rodda view on EDGAR
- - Chad Patterson view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where IRTC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IRTC with a 7-day demo
- IRTC on your watchlist
- Every IRTC Form 4 filing on record
- Up to 3 months of IRTC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive